Disc Medicine IRON Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's cash & equivalents?
- Disc Medicine (IRON) reported cash & equivalents of $88.91M in Q1 2026.
- How has Disc Medicine's cash & equivalents changed year-over-year?
- Disc Medicine's cash & equivalents decreased by 27.5% year-over-year, from $122.68M to $88.91M.
- What is the long-term trend for Disc Medicine's cash & equivalents?
- Over 5 years (2020 to 2025), Disc Medicine's cash & equivalents has grown at a 82.5% compound annual growth rate (CAGR), from $4.5M to $91.15M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.